CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
MED3000 topical geldevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05673005
NCT05673005N/ACompleted
CompareCT.gov

MED3000 Topical Gel for On-Demand Treatment of Post-Radical Prostatectomy Erectile Dysfunction

Brigham and Women's Hospital·interventional·Posted Jan 5, 2023·Updated Mar 11, 2026

In Brief

A clinical study evaluating MED3000 topical gel for Erectile Dysfunction Following Radical Prostatectomy. Completed, enrolled 20 participants across 1 site.

Detailed Summary

The investigators are doing this research to evaluate the efficacy and safety of topical MED3000 therapy in men with persistent erectile dysfunction 1.5 to 4 years following radical prostatectomy surgery.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsErectile Dysfunction Following Radical Prostatectomy
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedJan 5, 2023
Enrollment StartApr 1, 2023
Primary CompletionJul 24, 2024
Study CompletionAug 9, 2024
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 3.5 years ago

Interventions

MED3000 topical geldevice

Topical gel that has been shown to improve erectile dysfunction when used as needed.